Data compiled by Redley Lamar · ChainSifter Intelligence
6Suppliers
4Customers
3Debt Items
1Related Chains
Source-Backed Evidence Depth
Sunshine Biopharma, Inc. (SBFM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
14Total relationships
3Distinct source URLs
11High confidence
0.850Average confidence
2026-10-29Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Sunshine Biopharma, Inc. Suppliers
Ticker
Name
Confidence
Evidence
AEGIS-CAPITAL-CORP
AEGIS-CAPITAL-CORP
92%
On May 18, 2026, Sunshine Biopharma Inc. (the “Company”) entered into a placement agent agreement (the “Placement Agent Agreement”) with Aegis Capital Corp. (the “Placement Agent”),
MR-MALEK-CHAMOUN
MR-MALEK-CHAMOUN
92%
The Company agreed to a $ 5,000,000 CAD ($ 3,632,000 USD) earnout amount payable to Mr. Malek Chamoun, the seller of Nora Pharma.
ADVANOMICS-CORPORATION
ADVANOMICS-CORPORATION
90%
10.1 Patent Purchase Agreement with Advanomics Corporation
ARIZONA-BOARD-OF-REGENTS-ON-BEHALF-OF-THE-UNIVER
ARIZONA-BOARD-OF-REGENTS-ON-BEHALF-OF-THE-UNIVER
90%
10.8 Research Agreement between the Company and Arizona Board of Regents on behalf of the University of Arizona
UNIVERSITY-OF-GEORGIA-RESEARCH-FOUNDATION-INC
UNIVERSITY-OF-GEORGIA-RESEARCH-FOUNDATION-INC
90%
10.7 Sponsored Research Agreement, dated October 6, 2020, between the Company and the University of Georgia Research Foundation, Inc.
Reciprocal relationship from SBFMW graph: otal Balance at December 31, 2021 ( ) ( ) Fractional shares issued for reverse stock split ( ) – – – – – Common stock and pre-funded warrants issued in publi…
Sunshine Biopharma, Inc. Customers
Ticker
Name
Confidence
Evidence
NORA-PHARMA-INC
NORA-PHARMA-INC
90%
Nora Pharma acquires the rights to import, market, sell and distribute the products in Canada by purchasing the drug dossiers from strategic partners.
PAN-CANADIAN-PHARMACEUTICAL-ALLIANCE
PAN-CANADIAN-PHARMACEUTICAL-ALLIANCE
80%
The most recent negotiations between the pan-Canadian Pharmaceutical Alliance, the entity that negotiates drug prices on behalf of the government, and the Canadian Generic Pharmaceutical Association …
Reciprocal relationship from SBFMW graph: otal Balance at December 31, 2021 ( ) ( ) Fractional shares issued for reverse stock split ( ) – – – – – Common stock and pre-funded warrants issued in publi…
MOUNTAIN-WEST-BUSINESS-SOLUTIONS-INC
MOUNTAIN-WEST-BUSINESS-SOLUTIONS-INC
62%
solidated Financial Statements December 31, 2025 and 2024 Note 1 – Description of Business The Company was incorporated under the name Mountain West Business Solutions, Inc. on August 31, 2006, in th…
Sunshine Biopharma, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
SBFM-DEBT
Debt stack $744,840
90%
Market cache reports total debt of $744,840.
SBFM-DEBT-12392
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
SBFM-DEBT-12391
Warrants outstanding: 2919812
90%
xbrl warrant detail from xbrl 2025-12-31.
Sunshine Biopharma, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Sunshine Biopharma, Inc..
Sunshine Biopharma, Inc. Ownership
Holder
Name
Confidence
Evidence
SBFM-OWNER-CITADEL-ADVISORS-LLC
Citadel Advisors Llc
90%
13F overlay lists Citadel Advisors Llc as top holder; 10 tracked holders.
Sunshine Biopharma, Inc. Extended Supply Chain Network
